171 related articles for article (PubMed ID: 7513300)
41. Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor.
Shapira L; Takashiba S; Amar S; Van Dyke TE
Oral Microbiol Immunol; 1994 Apr; 9(2):112-7. PubMed ID: 7516534
[TBL] [Abstract][Full Text] [Related]
42. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages.
Landmann R; Ludwig C; Obrist R; Obrecht JP
J Cell Biochem; 1991 Dec; 47(4):317-29. PubMed ID: 1724447
[TBL] [Abstract][Full Text] [Related]
43. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.
Weidemann B; Brade H; Rietschel ET; Dziarski R; Bazil V; Kusumoto S; Flad HD; Ulmer AJ
Infect Immun; 1994 Nov; 62(11):4709-15. PubMed ID: 7523297
[TBL] [Abstract][Full Text] [Related]
44. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
45. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
Lee JD; Kato K; Tobias PS; Kirkland TN; Ulevitch RJ
J Exp Med; 1992 Jun; 175(6):1697-705. PubMed ID: 1375269
[TBL] [Abstract][Full Text] [Related]
46. A region of human CD14 required for lipopolysaccharide binding.
Viriyakosol S; Kirkland TN
J Biol Chem; 1995 Jan; 270(1):361-8. PubMed ID: 7529231
[TBL] [Abstract][Full Text] [Related]
47. [The endotoxin receptor CD14].
Schütt C; Schumann R
Immun Infekt; 1993 Apr; 21(2):36-40. PubMed ID: 7687987
[TBL] [Abstract][Full Text] [Related]
48. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein.
Schletter J; Brade H; Brade L; Krüger C; Loppnow H; Kusumoto S; Rietschel ET; Flad HD; Ulmer AJ
Infect Immun; 1995 Jul; 63(7):2576-80. PubMed ID: 7540597
[TBL] [Abstract][Full Text] [Related]
49. Modulation of cell surface antigens and regulation of phagocytic activity mediated by CD11b in the monocyte-like cell line U937 in response to lipopolysaccharide.
Ikewaki N; Tamauchi H; Inoko H
Tissue Antigens; 1993 Sep; 42(3):125-32. PubMed ID: 8284785
[TBL] [Abstract][Full Text] [Related]
50. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.
Schumann RR
Res Immunol; 1992 Jan; 143(1):11-5. PubMed ID: 1373512
[TBL] [Abstract][Full Text] [Related]
51. Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria.
Duchow J; Marchant A; Crusiaux A; Husson C; Alonso-Vega C; De Groote D; Neve P; Goldman M
Infect Immun; 1993 Oct; 61(10):4280-5. PubMed ID: 7691746
[TBL] [Abstract][Full Text] [Related]
52. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes.
Fan ST; Edgington TS
J Immunol; 1993 Apr; 150(7):2972-80. PubMed ID: 8095957
[TBL] [Abstract][Full Text] [Related]
53. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14.
Schütt C; Schilling T; Grunwald U; Stelter F; Witt S; Krüger C; Jack RS
Res Immunol; 1995; 146(6):339-50. PubMed ID: 8719658
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the endotoxin receptor (CD14) in septic patients.
Birkenmaier C; Hong YS; Horn JK
J Trauma; 1992 Apr; 32(4):473-8; discussion 478-9. PubMed ID: 1373777
[TBL] [Abstract][Full Text] [Related]
55. Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Antal-Szalmás P; Poppelier MJ; Broekhuizen R; Verhoef J; van Strijp JA; van Kessel KP
Cytometry; 2000 Dec; 41(4):279-88. PubMed ID: 11084613
[TBL] [Abstract][Full Text] [Related]
56. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide.
Liu MK; Herrera-Velit P; Brownsey RW; Reiner NE
J Immunol; 1994 Sep; 153(6):2642-52. PubMed ID: 7521366
[TBL] [Abstract][Full Text] [Related]
57. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
[TBL] [Abstract][Full Text] [Related]
58. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood.
Marchant A; Duchow J; Delville JP; Goldman M
Eur J Immunol; 1992 Jun; 22(6):1663-5. PubMed ID: 1376269
[TBL] [Abstract][Full Text] [Related]
59. Soluble CD14 in serum mediates LPS-induced increase in permeability of bovine pulmonary arterial endothelial cell monolayers in vitro.
Ishii Y; Shuyi W; Kitamura S
Life Sci; 1995; 56(25):2263-72. PubMed ID: 7540708
[TBL] [Abstract][Full Text] [Related]
60. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.
Grey ST; Tsuchida A; Hau H; Orthner CL; Salem HH; Hancock WW
J Immunol; 1994 Oct; 153(8):3664-72. PubMed ID: 7523500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]